Table 4. Odds ratios for increased CIMT and metabolic syndrome according to hepatic triglyceride content.
Metabolic syndrome |
Increased CIMT |
|||
---|---|---|---|---|
OR(95% CI) | P-value | OR(95% CI) | P-value | |
Model 1 | 1.86(1.46–2.37) | <0.001 | 1.31(1.05–1.63) | 0.017 |
Model 2 | 1.46(1.13–1.88) | 0.004 | 1.27(1.01–1.60) | 0.043 |
Model 3 | — | — | 1.29(1.01–1.64) | 0.045 |
OR = odds ratio; CI = confidence interval; BMI = body mass index; HOMA-IR = homeostasis model assessment of insulin resistance; CIMT = carotid intima-media thickness;
Model 1: adjusted for age, gender, smoking, alcohol consumption, physical activity, and BMI.
Model 2: Model 1+adjusted for HOMA-IR and body fat.
Model 3: Model 2+adjusted for metabolic components, including glucose, triglyceride, HDL-c and blood pressure.